Home - Geneva Biotech
Geneva Biotech. Our Technology Platforms Insect Cells MammalianandPrimary Cells E.coli.
Read Geneva-biotech.com news digest here: view the latest Geneva Biotech articles and content updates right away or get to their most visited pages. Geneva-biotech.com is not yet rated by Alexa and its traffic estimate is unavailable. We haven’t detected security issues or inappropriate content on Geneva-biotech.com and thus you can safely use it. Geneva-biotech.com is hosted with CloudFlare, Inc. (United States) and its basic language is English.
- Content verdict: Safe
- Website availability: Live
- Language: English
- Last check:
-
N/A
Visitors daily -
N/A
Pageviews daily -
4
Google PR -
N/A
Alexa rank
Best pages on Geneva-biotech.com
-
Geneva Biotech has a vision to develop a world class portfolio of intelligent protein expression technologies.
-
Geneva Biotech Products | Geneva Biotech
Geneva Biotech Products, Protein Expression Technologies, Synthetic Biology Reagents, Baculovirus Expression Systems
-
Contact | Geneva Biotech | Geneva Biotech
Contact Geneva Biotech
Geneva-biotech.com news digest
-
5 years
T-Cell and B-Cell Transduction Technologies
Geneva Biotech releases the first efficient non-lentiviral transduction system for immortal T-cells and B-cells. Please see Mammalian Product Category “T-Cells B-Cells”
The post T-Cell and B-Cell Transduction Technologies appeared first on Geneva Biotech.... -
5 years
Many of Geneva Biotech’s industry leading baculoviral genomes are now available as competent cells in Europe, Asia, and North America !
The post Leading baculoviral genomes appeared first on Geneva Biotech. -
6 years
Disruptive discovery method for inhibitors of protein-protein interactions
Protein-Protein interactions (PPIs) are central to most essential cellular mechanisms including gene expression, protein translocation, cell cycle progression and signal transduction. Bellón-Echeverría et al. published in Scientific Reports a proof of...
-
6 years
13 Lab International Benchmarking Study Names EMBacY the World’s Best Baculoviru...
Stolt-Bergner et al. published in Journal of Structural Biology a benchmarking initiative in 13 independent labs to compare the world’s leading baculovirus expression systems. Geneva Biotech’s EMBacY virus was ranked #1 in performance.
The post 13 Lab International Benchmarking Study Names EMBacY the World’s Best Baculovirus appeared first on Geneva Biotech....
Domain history
Web host: | CloudFlare, Inc. |
Registrar: | GoDaddy.com, LLC |
Registrant: | Registration Private (Domains By Proxy, LLC) |
Updated: | June 07, 2019 |
Expires: | June 12, 2024 |
Created: | June 12, 2012 |
Whois record
Safety scores
Trustworthiness
N/AChild safety
N/A